Open AccessThe hydroxychloroquine debate: a therapeutic dilemma for general practitioners
Author(s) -
Romain Lutaud,
Dimitri Scronias,
Jeremy K. Ward,
Pierre Verger
Publication year - 2021
Publication title -
european journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 91
eISSN - 1464-360X
pISSN - 1101-1262
DOI - 10.1093/eurpub/ckab002
Subject(s) - hydroxychloroquine , dilemma , covid-19 , epicenter , medicine , unit (ring theory) , family medicine , political science , psychology , virology , philosophy , epistemology , outbreak , pathology , mathematics education , civil engineering , disease , infectious disease (medical specialty) , engineering
France has been at the epicenter of the worldwide debate about hydroxychloroquine, as the main advocacy for its use to treat COVID-19 comes from a research unit led by Didier Raoult in Marseille. Among a national panel of 2940 general practitioners, we found that physicians in the areas most strongly affected by the epidemic or closest to the epicenter of the controversy reported that the hydroxychloroquine debate had made it difficult for them to deal with patients' treatment requests. Their adherence to official recommendations was also lower. It will be necessary to examine the conditions producing so strong a conflict.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom